This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Legacy software systems no longer make sense for life sciences businesses, especially those in Pharmaceutical manufacturing. The problem is that complexity, regulation, and competition have changed how pharmaceutical and life sciences firms must do business. Data is siloed, hard to update, and time-consuming to store or use.
This new Insights Post explores how the SAP ecosystem can help life sciences companies align initiatives in both of these areas with digital transformation initiatives that embrace new subscription-based revenue opportunities and simultaneously map out an optimized roadmap for moving to more efficient cloud-based ERP and overall business systems.
A finance director at a large niche pharmaceutical company told us: “We have a lot of manual processes and inputting and that type of stuff which I am trying to get away from. We found that the biggest unspoken challenge weighing down finance teams is still manual Excel processes. These processes vary.
A finance director at a large niche pharmaceutical company told us: “We have a lot of manual processes and inputting and that type of stuff which I am trying to get away from. We found that, despite 2024 being in full swing, the biggest unspoken challenge weighing down finance teams are still manual Excel processes. These processes vary.
We organize all of the trending information in your field so you don't have to. Join 39,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content